You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 28, 2025

Drug Price Trends for NDC 60505-4372


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 60505-4372

Drug NameNDCPrice/Unit ($)UnitDate
VILAZODONE HCL 10 MG TABLET 60505-4372-03 1.04482 EACH 2025-04-23
VILAZODONE HCL 10 MG TABLET 60505-4372-03 1.04549 EACH 2025-03-19
VILAZODONE HCL 10 MG TABLET 60505-4372-03 1.03171 EACH 2025-02-19
VILAZODONE HCL 10 MG TABLET 60505-4372-03 0.97547 EACH 2025-01-22
VILAZODONE HCL 10 MG TABLET 60505-4372-03 0.97183 EACH 2024-12-18
VILAZODONE HCL 10 MG TABLET 60505-4372-03 0.84323 EACH 2024-11-20
>Drug Name>NDC>Price/Unit ($)>Unit>Date
Showing 1 to 6 of 6 entries

Best Wholesale Price for NDC 60505-4372

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)DatesPrice Type
No data available in table
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 0 to 0 of 0 entries

Market Analysis and Price Projections for the Drug NDC: 60505-4372

Understanding the National Drug Code (NDC)

To analyze the market and project prices for a drug identified by the NDC 60505-4372, it is crucial to understand what an NDC represents. The National Drug Code (NDC) is a unique, 10-digit, three-segment numeric identifier assigned to each medication. It identifies the labeler, product, and trade package size of the drug[5].

Breakdown of the NDC 60505-4372

  • Labeler Code: The first segment (60505) is assigned by the FDA and identifies the firm that manufactures, repacks, or distributes the drug.
  • Product Code: The second segment identifies a specific strength, dosage form, and formulation for the particular firm.
  • Package Code: The third segment identifies the package sizes and types.

Market Trends and Price Inflation

Overall Drug Price Inflation

The pharmaceutical market is expected to see a continued rise in drug prices. According to Vizient's summer Pharmacy Market Outlook, the overall drug price inflation rate for pharmaceuticals in 2025 is projected to be 3.81%[4].

Impact of Expanding Indications

Drugs with expanding indications, such as semaglutide, have seen significant increases in spend. This trend suggests that drugs with multiple approved uses can drive up costs due to increased demand and broader therapeutic applications[4].

Specific Drug Price Projections

Historical Price Increases

The pharmaceutical industry has seen substantial price increases, particularly for generic drugs. For instance, a generic version of naproxen saw a 2,527% price increase between 2012 and 2021[2]. While this is an extreme example, it highlights the potential for significant price fluctuations.

Regulatory Oversight and Transparency

Efforts to increase transparency and regulate drug prices, such as those in Oregon, aim to provide more insight into the factors influencing drug costs. However, gaps in transparency, especially regarding rebates, discounts, and other financial negotiations, can still affect price projections[2].

Factors Influencing Drug Prices

Pharmaceutical Supply Chain

The price of a prescription drug is influenced by interactions and financial negotiations between various entities in the pharmaceutical supply chain, including manufacturers, pharmacy benefit managers (PBMs), and health insurers. These interactions can lead to significant variations in drug prices[2].

Use of AI and Data Trends

The increasing adoption of artificial intelligence (AI) and external data in pharmaceutical companies may impact drug development and pricing. AI can help in predicting market trends and optimizing pricing strategies, but it also introduces new complexities and challenges in data reliability and trustworthiness[3].

Billing and Reporting Considerations

When billing for drugs using NDCs, it is essential to convert the amount of the drug administered into the correct units of measure. For example, for liquid, solution, or suspension medications, the amount must be converted from milligrams (MG) to milliliters (ML) to match the NDC description[1].

Case Study: Similar Drugs

To project prices for the drug NDC 60505-4372, one can look at similar drugs within the same therapeutic class or those with similar indications. For instance, if the drug in question is a high-cost medication like Carvykti (with a reported WAC of $465,000), any price projection would need to consider the high-cost nature and potential regulatory oversight[2].

Key Takeaways

  • NDC Understanding: The NDC is a critical identifier for drugs, breaking down into labeler, product, and package codes.
  • Market Trends: Overall drug price inflation is projected at 3.81% for 2025, with significant increases for drugs with expanding indications.
  • Regulatory Environment: Transparency and regulatory efforts can impact price projections, but gaps in transparency remain.
  • AI and Data: Increasing use of AI and external data may influence pricing strategies and market trends.
  • Billing Considerations: Accurate conversion of drug amounts to match NDC descriptions is crucial for billing.

FAQs

Q: What does the NDC 60505-4372 represent? A: The NDC 60505-4372 is a unique identifier for a specific drug product, breaking down into labeler, product, and package codes.

Q: What is the projected drug price inflation rate for 2025? A: The overall drug price inflation rate for pharmaceuticals in 2025 is projected to be 3.81% according to Vizient's summer Pharmacy Market Outlook[4].

Q: How do expanding indications affect drug prices? A: Expanding indications can significantly increase the demand and spend on a drug, as seen with semaglutide, which increased 77% in spend due to new approved uses[4].

Q: What role does AI play in pharmaceutical pricing? A: AI is increasingly used in pharmaceutical companies to optimize pricing strategies and predict market trends, but it also introduces complexities in data reliability and trustworthiness[3].

Q: Why is transparency important in drug pricing? A: Transparency helps in understanding the factors influencing drug costs, including interactions between supply chain entities, and can lead to more informed policy decisions and better cost management[2].

Sources

  1. Billing with National Drug Codes (NDCs) Frequently Asked Questions - Blue Cross Blue Shield of Illinois.
  2. Prescription Drug Price Transparency Results and Recommendations - Oregon Department of Consumer and Business Services.
  3. 2025 Pharma Predictions: AI, Health Tech, and Data Trends to Watch - Intelligencia AI.
  4. Vizient projects drug price inflation at 3.81% - Vizient, Inc.
  5. National Drug Code Database Background Information - FDA.

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.